Everett Stone

8.6k total citations · 2 hit papers
56 papers, 2.4k citations indexed

About

Everett Stone is a scholar working on Molecular Biology, Biotechnology and Biochemistry. According to data from OpenAlex, Everett Stone has authored 56 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 21 papers in Biotechnology and 18 papers in Biochemistry. Recurrent topics in Everett Stone's work include Cancer Research and Treatments (21 papers), Amino Acid Enzymes and Metabolism (17 papers) and Virus-based gene therapy research (13 papers). Everett Stone is often cited by papers focused on Cancer Research and Treatments (21 papers), Amino Acid Enzymes and Metabolism (17 papers) and Virus-based gene therapy research (13 papers). Everett Stone collaborates with scholars based in United States, Poland and Japan. Everett Stone's co-authors include George Georgiou, Walter Fast, Scott W. Rowlinson, David L. Tierney, Candice Lamb, Kendra Triplett, Lynne Chantranupong, John DiGiovanni, Achinto Saha and Pei W. Thomas and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Medicine and Journal of Clinical Oncology.

In The Last Decade

Everett Stone

55 papers receiving 2.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Systemic depletion of L-cyst(e)ine with cyst(e)inase increases reactive oxygen species and suppresses tumor growth

2016 431 citations Achinto Saha, Stefano Tiziani et al. profile →
Non-canonical Glutamate-Cysteine Ligase Activity Protects against Ferroptosis

2020 248 citations Yun Pyo Kang, Chang Jiang et al. Cell Metabolism profile →

Peers

Countries citing papers authored by Everett Stone

Since Specialization

Citations

This map shows the geographic impact of Everett Stone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Everett Stone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Everett Stone more than expected).

Fields of papers citing papers by Everett Stone

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Everett Stone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Everett Stone. The network helps show where Everett Stone may publish in the future.

Co-authorship network of co-authors of Everett Stone

This figure shows the co-authorship network connecting the top 25 collaborators of Everett Stone. A scholar is included among the top collaborators of Everett Stone based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Everett Stone. Everett Stone is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Cysteine depletion sensitizes prostate cancer cells to agents that enhance DNA damage and to immune checkpoint inhibition 2023 ·Journal of Experimental & Clinical Cancer Research ·Achinto Saha, Shengyuan Zhao, (unknown), (unknown), (unknown), Rachel M. Clark, George Georgiou, Everett Stone, Dawit Kidane, John DiGiovanni	15
2	Enzymatic depletion of l‐Met using an engineered human enzyme as a novel therapeutic strategy for melanoma 2023 ·Molecular Carcinogenesis ·(unknown), (unknown), Anna Battenhouse, Achinto Saha, (unknown), Eunice Kim, (unknown), Stefano Tiziani, George Georgiou, Everett Stone, John DiGiovanni	1
3	Leveraging intrinsic flexibility to engineer enhanced enzyme catalytic activity 2022 ·Proceedings of the National Academy of Sciences ·Christos S. Karamitros, (unknown), (unknown), Candice Lamb, Everett Stone, Sheena D’Arcy, Kenneth A. Johnson, George Georgiou	26
4	Conformational Dynamics Contribute to Substrate Selectivity and Catalysis in Human Kynureninase 2020 ·ACS Chemical Biology ·Christos S. Karamitros, (unknown), Yusuke Sugiyama, Yoichi Kumada, Kenneth A. Johnson, George Georgiou, Sheena D’Arcy, Everett Stone	6
5	Non-canonical Glutamate-Cysteine Ligase Activity Protects against Ferroptosis breakdown → 2020 ·Cell Metabolism ·Yun Pyo Kang, (unknown), Chang Jiang, Aimee Falzone, Nicolas Prieto-Farigua, Everett Stone, Isaac S. Harris, Gina M. DeNicola	248
6	Combinatorial Approaches to Enhance DNA Damage following Enzyme-Mediated Depletion of L-Cys for Treatment of Pancreatic Cancer 2020 ·Molecular Therapy ·Achinto Saha, Shengyuan Zhao, Chen Zhao, George Georgiou, Everett Stone, Dawit Kidane, John DiGiovanni	15
7	Enzyme-mediated depletion of l-cyst(e)ine synergizes with thioredoxin reductase inhibition for suppression of pancreatic tumor growth 2019 ·npj Precision Oncology ·(unknown), Achinto Saha, (unknown), Stefano Tiziani, Everett Stone, George Georgiou, John DiGiovanni	35
8	Optimization of a nicotine degrading enzyme for potential use in treatment of nicotine addiction 2019 ·BMC Biotechnology ·Thomas Thisted, (unknown), Céline Walmacq, Everett Stone, (unknown), Shaheda Ahmed, Stephen Horrigan, (unknown), Charles C. Reed, Matthew W. Kalnik	18
9	A randomized phase II trial of CRLX101 in combination with bevacizumab versus standard of care in patients with advanced renal cell carcinoma 2017 ·Annals of Oncology ·Martin H. Voss, Arif Hussain, Nicholas J. Vogelzang, (unknown), Bhumsuk Keam, Sun Young Rha, Ulka N. Vaishampayan, Wayne Harris, Stephen Richey, James M. Randall, David R. Shaffer, Allen Lee Cohn, (unknown), (unknown), Adrian M. Senderowicz, Everett Stone, Robert A. Figlin, Robert J. Motzer, Naomi B. Haas, Thomas E. Hutson	66
10	Oncogene-Selective Sensitivity to Synchronous Cell Death following Modulation of the Amino Acid Nutrient Cystine 2017 ·Cell Reports ·(unknown), Xiaomeng Wang, (unknown), Christiaan F. Labuschagne, David Y. Mason, (unknown), Kendra Triplett, Rajat Roy, Olivier E. Pardo, Michael J. Seckl, Scott W. Rowlinson, Everett Stone, Richard F. Lamb	206
11	A missense mutation inASRGL1is involved in causing autosomal recessive retinal degeneration 2016 ·Human Molecular Genetics ·Pooja Biswas, Venkata Ramana Murthy Chavali, (unknown), Everett Stone, Christina Chakarova, Jacque L. Duncan, Chitra Kannabiran, (unknown), Shomi S. Bhattacharya, Muhammad Asif Naeem, (unknown), Dror Sharon, Takeshi Iwata, (unknown), G. Bhanuprakash Reddy, J. Fielding Hejtmancik, George Georgiou, Sheikh Riazuddin, Radha Ayyagari	12
12	Human recombinant arginase enzyme reduces plasma arginine in mouse models of arginase deficiency 2015 ·Human Molecular Genetics ·Lindsay C. Burrage, Qin Sun, Sarah H. Elsea, Ming‐Ming Jiang, Sandesh C.S. Nagamani, Arthur E. Frankel, Everett Stone, Susan E. Alters, Dale E. Johnson, Scott W. Rowlinson, George Georgiou, Brendan Lee	38
13	In-vivo evaluation of human recombinant Co-arginase against A375 melanoma xenografts 2014 ·Melanoma Research ·Vaidehi Agrawal, Jung Hee Woo, Jeremy Mauldin, Everett Stone, Cynthia J. Meininger, Chan‐Hee Jo, (unknown), Eugene P. Frenkel, Arthur E. Frankel	2
14	SCHEMA-Designed Variants of Human Arginase I and II Reveal Sequence Elements Important to Stability and Catalysis 2012 ·ACS Synthetic Biology ·Philip A. Romero, Everett Stone, Candice Lamb, Lynne Chantranupong, Andreas Krause, Aleksandr E. Miklos, Randall A. Hughes, (unknown), Andrew D. Ellington, Frances H. Arnold, George Georgiou	40
15	Engineering Reduced-Immunogenicity Enzymes for Amino Acid Depletion Therapy in Cancer 2011 ·Methods in enzymology on CD-ROM/Methods in enzymology ·Jason R. Cantor, (unknown), (unknown), George Georgiou, Everett Stone	42
16	Targeting methionine auxotrophy in cancer: discovery & exploration 2011 ·Expert Opinion on Biological Therapy ·Vaidehi Agrawal, (unknown), Everett Stone, Eugene P. Frenkel, Arthur E. Frankel	27
17	Cytotoxicity of human recombinant arginase I (Co)-PEG5000 in the presence of supplemental L-citrulline is dependent on decreased argininosuccinate synthetase expression in human cells 2011 ·Anti-Cancer Drugs ·Vaidehi Agrawal, Jung Hee Woo, Jeremy Mauldin, Chan‐Hee Jo, Everett Stone, George Georgiou, Arthur E. Frankel	26
18	Promiscuous Partitioning of a Covalent Intermediate Common in the Pentein Superfamily 2008 ·Chemistry & Biology ·Thomas W. Linsky, A.F. Monzingo, Everett Stone, Jon D. Robertus, Walter Fast	7
19	THE QUORUM-QUENCHING LACTONASE FROM BACILLUS THURINGIENSIS IS A METALLOPROTEIN 2005 ·Macromolecules ·Pei W. Thomas, Everett Stone, (unknown), David L. Tierney, Walter Fast	1
20	A continuous spectrophotometric assay for dimethylarginine dimethylaminohydrolase 2005 ·Analytical Biochemistry ·Everett Stone, Walter Fast	10

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact